NCT05883163
STIMIT Activator 1 IDE Study
At risk: Primary completion moved at least 8 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Apr 2026 to Jan 2027 Show 6 more changesShow less
- Eligibility criteria expanded, about 17 words
- Study completion pushed from Jul 2026 to May 2027
- Secondary endpoints revised (3)
- Site details revised at 2 of 4 sites
- Publications: details revised at 1 of 1 entry
- Study description expanded, about 4 words
Notable Primary completion date: Dec 31, 2024 to Apr 2026v5 Show 8 more changesShow less
- Start date: Nov 7, 2023 to Jan 24, 2024
- Primary endpoints revised (2)
- Eligibility criteria shortened, about 1 word
- Study sites: 3 to 4
- Study completion date: Mar 31, 2025 to Jul 2026
- Secondary endpoints: details revised at 3 of 3 entries
- Study description shortened, about 109 words
- Study title shortened, about 1 word
Notable Trial status: Not Yet Recruiting to Recruitingv4 Show 5 more changesShow less
- Primary completion date: Feb 5, 2024 to Dec 31, 2024
- Study sites: 0 to 3
- Study completion date: Feb 5, 2024 to Mar 31, 2025
- Start date changed from estimate of Sep 15, 2023 to Nov 7, 2023
- Study title expanded, about 1 word
- Minor Secondary endpoints revised (3)v3
Notable Start date: Jul 5, 2023 to Sep 15, 2023v2 Show 4 more changesShow less
- Eligibility criteria shortened, about 33 words
- Primary endpoints revised (2)
- Secondary endpoints: 1 to 3
- Study description shortened, about 1 word
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Efffectiveness: Preservation of Diaphragm Thickness
Timeframe: Up to Day 10
Safety: Rate of device or procedure related serious adverse events (SAEs)
Timeframe: Up to Day 10
Secondary (3)
Mechanical Ventilation (MV) Duration
Preservation of Diaphragm Thickness
Time to Rapid Shallow Breathing Index (RSBI) < 105
Arms and interventions
Stimulation GroupExperimental
The intervention group will receive non-invasive stimulation of the phrenic nerve for activation of the diaphragm.
Control GroupNo intervention
The control group will not received intervention and will be treated with standard of care.
Devices: Stimit Activator 1
Sites
4 sites in 2 countries
United States 3, Canada 1